1. Home
  2. TELA vs EVAX Comparison

TELA vs EVAX Comparison

Compare TELA & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.85

Market Cap

37.5M

Sector

Health Care

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.82

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TELA
EVAX
Founded
2012
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.5M
27.4M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
TELA
EVAX
Price
$0.85
$3.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$3.31
$11.67
AVG Volume (30 Days)
53.3K
29.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
34.80
N/A
EPS
N/A
N/A
Revenue
$69,300,000.00
N/A
Revenue This Year
$18.41
N/A
Revenue Next Year
$15.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.56
N/A
52 Week Low
$0.67
$1.20
52 Week High
$2.48
$12.15

Technical Indicators

Market Signals
Indicator
TELA
EVAX
Relative Strength Index (RSI) 47.43 53.01
Support Level $0.67 $2.45
Resistance Level $1.22 $5.48
Average True Range (ATR) 0.09 0.34
MACD -0.00 0.11
Stochastic Oscillator 46.27 47.43

Price Performance

Historical Comparison
TELA
EVAX

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: